Prof. John Todd

Professor of Precision Medicine, University of Oxford

Professor John Todd is Professor of Precision Medicine at the University of Oxford, Co-Director of the Oxford–GSK Institute of Molecular and Computational Medicine (IMCM), and Principal Investigator of Diabetes and Inflammation Laboratory (DIL). He is also an Emeritus Senior Investigator of the National Institute for Health Research. Until 2016, he was Professor of Medical Genetics at the University of Cambridge, and prior to this, Professor of Human Genetics and a Wellcome Trust Principal Research Fellow at the University of Oxford.

Professor Todd obtained his PhD in Biochemistry at the University of Cambridge. He helped pioneer genome-wide genetic studies in common diseases and then went on to study the associations between disease-associated genetic variants and phenotypes in type 1 diabetes (T1D) by founding and deploying the Cambridge BioResource. He researches T1D genetics and disease mechanisms with the goal of delivering clinical interventions. He is also part of the international consortium, the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD), and most recently collaborating with the Bukhman Foundation in establishment of the Centre for Research Excellence in Type 1 diabetes in Oxford.

Professor Todd’s research in genetics and diabetes has received several awards and prizes, including the 1995 Minkowski Prize of the European Association for the Study of Diabetes (EASD) and the 2021 EASD/Novo Nordisk Foundation Diabetes Prize for Excellence. He has supervised 40 PhD and MSc students, with three in progress, and has an h-index of 131 with over 40,000 citations.

BACK